We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (17)
- Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1046 result(s) found, displaying 326 to 350
-
Market actionsHazard alert and recall for product correction - urgent software updates needed
-
Safety alertsSLAM Natural Formula 29000 mg capsules pose a serious risk to your health and should not be taken
-
Safety alertsSafety Alert- Semenax capsules (counterfeit version)
-
-
Safety alertsUpdate following revocation of suspension
-
Safety alertsThis review concerns the safety of use of codeine-containing products in children in the context of ultra-rapid metabolisers
-
-
-
Safety alertsRed Ant tablets pose a serious risk to your health and should not be taken.
-
Safety alertsSafety Alert - Maximum Powerful (Baiwei USA) tablets
-
Safety alertsSafety advisory – risk of serious injury or death due to incorrect instruction artwork
-
-
-
Safety alertsSafety Alert- Beautiful Lose Weight Gold 30 Capsules
-
Safety alertsTamo 20 tablets may pose a serious risk to your health and should not be taken.
-
Market actionsRecall for product correction - potential for injury due to breakage of the seating system
-
Market actionsRecall - may pose a serious health hazard to children
-
-
Market actionsRecall – potential for allergic reactions due to higher than expected amounts of histamine
-
Market actionsRecall for product correction - may cause interference with mobile towers
-
Market actionsRecall – potential for incomplete delivery of medication
-
Safety alertsThe TGA cancelled all medical devices manufactured by Silimed from the Australian Register of Therapeutic Goods on 5 November 2016
-
Market actionsRecall – potential for injury as a result of breakage
-
-